Neurocrine Bioscienc (NBIX)
$106.81
3.80 (3.44%)
18:34 EST
NBIX Stock Quote Delayed 30 Minutes
Previous Close
-
Market Cap
9.60B
PE Ratio
-89.76
EPS
-1.19
Volume (Avg. Vol.)
582,858
Day's Range
106.75 - 110.89
52-Week Range
72.14 - 136.26
Dividend & Yield
N/A (N/A)
NBIX Stock Predictions, Articles, and Neurocrine Bioscienc News
- From InvestorPlace
- From the Web
3 Companies to Invest In for Mammoth Growth in 2021
Investors seeking strong growth companies to invest in should watch Credit Acceptance Corporation, RenaissanceRe and Neurocrine Biosciences.
7 Beautiful Biotech Stocks to Buy Here
Covid-19 has put the biotech stocks in the spotlight, but treatments for the pandemic are far from the only reason investors should watch this space.
8 Stocks to Buy That Are Growing Faster Than Amazon
Neurocrine Biosciences, Facebook and Etsy are just some of the stocks to buy if you want growth because they're outpacing Amazon.
10 Smart Money Stocks to Buy for the Rest of the Year
These 10 smart money stocks to buy have significant support from top analysts. Here's why each should help you flourish throughout the rest of the year.
6 Stocks Set for Monster Growth in 2019
Looking for stocks to buy now? These six companies are among the best stocks to invest in for their immaculate record from the Street's top analysts. Here's why:
5 Biotech Stocks That Could Face M&A Next!
Big biotech buyouts have already started happening. These five biotech stocks could be the next to go.
Neurocrine Biosciences Is a Pharma Stock to Watch
Biopharma company Neurocrine isn't letting a setback with one of its drugs stop it. Here's what to know about NBIX stock.
5 Pharma Stocks to Stay Away From
With an aging population, pharma stocks can be a very profitable investments. These 5 biotechs probably aren't.
10 Fast-Growing Stocks With Monster Catalysts This Summer
A slow summer puts a premium on fast-growing stocks, and even more so on names that are headed into some splashy headlines.
5 Biotech Stocks That Could Be the Next Amgen
Looking for the next big biotech stock? Skip the clinical ones and focus on those with approved drugs. Here are 5 biotech stocks to buy today.
3 Stocks to Watch on Wednesday: Tesla, Inc. (TSLA), Delta Air Lines, Inc. (DAL) and Neurocrine Biosciences, Inc. (NBIX)
Delta Air Lines (DAL) pops on solid Q1 earnings, a major investor questions Tesla's (TSLA) board and Neurocrine Biosciences (NBIX) is flying on an FDA approval.
10 Small-Cap Stocks That Could Double in the Next 3 Months
These small-cap stocks all have the potential to dish out misery, but if things work out just right, look out above.
40 Biotechnology Stocks to Sell Now
This week, the overall grades of 40 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
40 Biotechnology Stocks to Sell Now
The overall ratings of 40 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
52 Biotechnology Stocks to Sell Now
The overall ratings of 52 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
30 Biotechnology Stocks to Sell Now
The ratings of 30 Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
26 Biotechnology Stocks to Sell Now
The ratings of 26 Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Hottest Manufacturing Stocks Now – JAGX GBIM PRTK TROX
The following stocks were moving the Manufacturing sector today.
9 Biotechnology Stocks to Buy Now
This week, 9 Biotechnology stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy").
Hottest Manufacturing Stocks Now – CPXX BOSC TTM CYTR
The following stocks were the biggest movers and shakers in the Manufacturing sector today.

Navellier Ratings
Powered by Portfolio GraderTotal Grade
C
Hold